TAZ antibody (AA 174-248)
Quick Overview for TAZ antibody (AA 174-248) (ABIN6148874)
Target
See all TAZ AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    
- 
                                            
Binding Specificity
 - AA 174-248
 - 
                                            
Sequence
 - NDVLPNSPPY FPRFGQKITV LIGKPFSALP VLERLRAENK SAVEMRKALT DFIQEEFQHL KTQAEQLHNH LQPGR
 - 
                                            
Cross-Reactivity
 - Human, Mouse, Rat
 - 
                                            
Characteristics
 - Polyclonal Antibodies
 - 
                                            
Immunogen
 - Recombinant fusion protein containing a sequence corresponding to amino acids 174-248 of human Tafazzin / TAZ (NP_851830.1).
 - 
                                            
Isotype
 - IgG
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - WB,1:1000 - 1:2000
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Liquid
 - 
                                            
Buffer
 - PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
 - 
                                            
Preservative
 - Sodium azide
 - 
                                            
Precaution of Use
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Storage
 - -20 °C
 - 
                                            
Storage Comment
 - Store at -20°C. Avoid freeze / thaw cycles.
 
 - 
                                            
 - 
    
- TAZ (Tafazzin (TAZ))
 - 
                                            
Alternative Name
 - TAZ
 - 
                                            
Background
 - This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,TAZ,BTHS,CMD3A,EFE,EFE2,G4.5,LVNCX,Taz1,tafazzin,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,TAZ
 - 
                                            
Molecular Weight
 - 25 kDa/27 kDa/28 kDa/29 kDa/30 kDa/31 kDa/33 kDa
 - 
                                            
Gene ID
 - 6901
 - 
                                            
UniProt
 - Q16635
 
Target
 -